These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29951170)

  • 21. Persistent serpentine supravenous hyperpigmented eruption in leprosy.
    Kavak A; Karahacıoğlu FB; Gül İ; Taşmalı MK; Cimilli T; Baytekin F
    J Am Acad Dermatol; 2012 Aug; 67(2):e77-8. PubMed ID: 22794822
    [No Abstract]   [Full Text] [Related]  

  • 22. Serpentine supravenous hyperpigmentation due to hydroxychloroquine.
    Lau JF; Dean SM; Rooke TW; Olin JW
    Vasc Med; 2016 Dec; 21(6):558-559. PubMed ID: 27197682
    [No Abstract]   [Full Text] [Related]  

  • 23. Supravenous hyperpigmentation, transverse leuconychia and transverse melanonychia after chemotherapy for Hodgkin's disease.
    Lang K; Groeger M; Neumann NJ; Ruzicka T; Fritsch C
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):162-3. PubMed ID: 12046824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serpentine supravenous streaks induced by 5-fluorouracil.
    Jain V; Bhandary S; Prasad GN; Shenoi SD
    J Am Acad Dermatol; 2005 Sep; 53(3):529-30. PubMed ID: 16112371
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy-induced persistent serpentine supra-venous hyperpigmented eruption and persistent supra-venous erythematous eruption: case report.
    Marongiu P; Lissia A; Cottoni F
    G Ital Dermatol Venereol; 2009 Feb; 144(1):97-100. PubMed ID: 19218916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation.
    Hrushesky WJ
    Cancer Treat Rep; 1976 May; 60(5):639. PubMed ID: 991154
    [No Abstract]   [Full Text] [Related]  

  • 28. Supravenous hyperpigmentation induced by vinorelbine.
    Cecchi R; Tuci F; Giomi A; Innocenti F
    Dermatology; 1994; 188(3):244. PubMed ID: 8186521
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Serpentine supravenous fluorouracil hyperpigmentation.
    Hrushesky WJ
    JAMA; 1976 Jul; 236(2):138. PubMed ID: 947001
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
    Sibaud V; Fricain JC; Baran R; Robert C
    Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth.
    Lee EJ; Ahn KH; Hong SC; Lee EH; Park Y; Kim BS
    Obstet Gynecol Sci; 2014 Nov; 57(6):526-9. PubMed ID: 25469343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supravenous discoloration of the skin due to docetaxel treatment.
    Schrijvers D; Van Den Brande J; Vermorken JB
    Br J Dermatol; 2000 May; 142(5):1069-70. PubMed ID: 10809894
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.
    Huang JJ; Xia Y; Wang Y; Liu PP; Bi XW; Sun P; Lin TY; Jiang WQ; Li ZM
    Oncotarget; 2016 Jul; 7(27):41242-41250. PubMed ID: 27183909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous reaction associated with weekly docetaxel administration.
    Chew L; Chuen VS
    J Oncol Pharm Pract; 2009 Mar; 15(1):29-34. PubMed ID: 18753180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.
    Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ
    Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual pigmentary changes associated with 5-fluorouracil therapy.
    Hrushesky WJ
    Cutis; 1980 Aug; 26(2):181-82. PubMed ID: 7408538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma.
    Sohn BS; Kim SM; Yoon DH; Kim S; Lee DH; Kim JH; Lee SW; Huh J; Suh C
    Ann Hematol; 2012 Nov; 91(11):1731-9. PubMed ID: 22752193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supravenous Hyperpigmentation in an HIV-Infected Patient.
    Gilmour J; Bates D; Olsen G; Saade A
    Skinmed; 2016; 14(2):135-7. PubMed ID: 27319961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.
    Knight C; Hind D; Brewer N; Abbott V
    Health Technol Assess; 2004 Sep; 8(37):iii, ix-xi, 1-82. PubMed ID: 15361313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.